TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2242194
log Bayes Factor = 0.111766
Chromosome 1   position 154,990,297  (GRCh37) Explore rs2242194 on Ensembl!
Variant rs2242194 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
Z51.2 Other chemotherapy
0.000 0.858 0.142
E03.9 Hypothyroidism, unspecified
0.000 0.880 0.120
Z83.5 Family history of eye and ear disorders
0.000 0.931 0.069
E03 Other hypothyroidism
0.000 0.946 0.053
C44.4 Skin of scalp and neck
0.000 0.954 0.046
C44 Other malignant neoplasms of skin
0.000 0.956 0.044
C44.5 Skin of trunk
0.000 0.957 0.043
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.958 0.042
C43 Malignant melanoma of skin
0.000 0.958 0.042
C43.5 Malignant melanoma of trunk
0.000 0.960 0.040
C43-C44 Melanoma and other malignant neoplasms of skin
0.000 0.960 0.040
C43.6 Malignant melanoma of upper limb, including shoulder
0.000 0.961 0.039
E03.1 Congenital hypothyroidism without goitre
0.000 0.961 0.039
E03.5 Myxoedema coma
0.000 0.961 0.038
E03.4 Atrophy of thyroid (acquired)
0.000 0.961 0.038
E03.3 Postinfectious hypothyroidism
0.000 0.961 0.038
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.961 0.038
C43.4 Malignant melanoma of scalp and neck
0.000 0.962 0.038
C44.3 Skin of other and unspecified parts of face
0.000 0.962 0.038
C44.9 Malignant neoplasm of skin, unspecified
0.000 0.964 0.036
C44.1 Skin of eyelid, including canthus
0.000 0.966 0.034
C43.9 Malignant melanoma of skin, unspecified
0.000 0.966 0.033
C43.1 Malignant melanoma of eyelid, including canthus
0.000 0.967 0.033
E03.8 Other specified hypothyroidism
0.000 0.968 0.032
C44.8 Overlapping lesion of skin
0.000 0.968 0.031
Z92.1 Personal history of long-term (current) use of anticoagulants
0.000 0.970 0.030
C43.8 Overlapping malignant melanoma of skin
0.000 0.970 0.030
C43.0 Malignant melanoma of lip
0.000 0.970 0.030
M25.75 Osteophyte (Pelvic region and thigh)
0.028 0.972 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.973 0.027
C43.2 Malignant melanoma of ear and external auricular canal
0.000 0.974 0.026
C44.2 Skin of ear and external auricular canal
0.000 0.977 0.023
C44.7 Skin of lower limb, including hip
0.000 0.978 0.022
K57.2 Diverticular disease of large intestine with perforation and abscess
0.022 0.978 0.000
C44.6 Skin of upper limb, including shoulder
0.000 0.982 0.018
N72 Inflammatory disease of cervix uteri
0.000 0.985 0.015
C44.0 Skin of lip
0.000 0.987 0.012
G20 Parkinson's disease
0.011 0.989 0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder
0.010 0.990 0.000
A09.9 Gastroenteritis and colitis of unspecified origin
0.000 0.990 0.010
E00-E07 Disorders of thyroid gland
0.000 0.990 0.010
D21 Other benign neoplasms of connective and other soft tissue
0.010 0.990 0.000
D21.2 Connective and other soft tissue of lower limb, including hip
0.009 0.991 0.000
D21.0 Connective and other soft tissue of head, face and neck
0.009 0.991 0.000
D21.9 Connective and other soft tissue, unspecified
0.009 0.991 0.000
D22.5 Melanocytic naevi of trunk
0.000 0.991 0.009
J86.9 Pyothorax without fistula
0.000 0.991 0.009
M25.57 Pain in joint (Ankle and foot)
0.000 0.992 0.008
C43.7 Malignant melanoma of lower limb, including hip
0.000 0.992 0.008
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.992 0.008
O62.3 Precipitate labour
0.000 0.992 0.008
Y54.5 Other diuretics
0.008 0.992 0.000
D21.4 Connective and other soft tissue of abdomen
0.008 0.992 0.000
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin
0.000 0.992 0.008
H02.4 Ptosis of eyelid
0.000 0.992 0.008
A09 Diarrhoea and gastro-enteritis of presumed infectious origin
0.000 0.992 0.008
E07 Other disorders of thyroid
0.000 0.992 0.008
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.993 0.007
D21.3 Connective and other soft tissue of thorax
0.007 0.993 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.993 0.007
E00 Congenital iodine-deficiency syndrome
0.000 0.993 0.007
D21.6 Connective and other soft tissue of trunk, unspecified
0.007 0.993 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.993 0.007
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.007 0.993 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.007 0.993 0.000
D21.5 Connective and other soft tissue of pelvis
0.006 0.994 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.994 0.006
C81.9 Hodgkin's disease, unspecified
0.006 0.994 0.000
R25.2 Cramp and spasm
0.000 0.994 0.006
Y41.0 Sulphonamides
0.006 0.994 0.000
Y41.5 Antiviral drugs
0.006 0.994 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.006 0.994 0.000
Y52 Agents primarily affecting the cardiovascular system
0.006 0.994 0.000
E05.8 Other thyrotoxicosis
0.000 0.994 0.006
M79.67 Pain in limb (Ankle and foot)
0.000 0.994 0.006
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.006 0.994 0.000
E07.1 Dyshormogenetic goitre
0.000 0.994 0.006
E07.0 Hypersecretion of calcitonin
0.000 0.994 0.006
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.006 0.994 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.994 0.006
E05.5 Thyroid crisis or storm
0.000 0.994 0.005
E05.4 Thyrotoxicosis factitia
0.000 0.994 0.005
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.994 0.005
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.994 0.005
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.995 0.005
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.995 0.005
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.995 0.005
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.995 0.005
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.995 0.005
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.995 0.005
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.995 0.005
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.995 0.005
Y52.4 Angiotensin-converting-enzyme inhibitors
0.005 0.995 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.995 0.000
Y54.8 Agents affecting uric acid metabolism
0.005 0.995 0.000
O62.2 Other uterine inertia
0.000 0.995 0.005
E07.8 Other specified disorders of thyroid
0.000 0.995 0.005
Y54.3 Benzothiadiazine derivatives
0.005 0.995 0.000
Y48 Anaesthetics and therapeutic gases
0.005 0.995 0.000
Y54.7 Agents affecting calcification
0.005 0.995 0.000
M81.49 Drug-induced osteoporosis (Site unspecified)
0.005 0.995 0.000
M81.98 Osteoporosis, unspecified (Other)
0.005 0.995 0.000
Y54.9 Mineral salts, not elsewhere classified
0.005 0.995 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.005 0.995 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.005 0.995 0.000
Y54.0 Mineralocorticoids
0.005 0.995 0.000
J86 Pyothorax
0.000 0.995 0.005
Y46 Antiepileptics and anti-Parkinsonism drugs
0.005 0.995 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.005 0.995 0.000
C81 Hodgkin's disease
0.005 0.995 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.995 0.000
Y41.4 Anthelminthics
0.005 0.995 0.000
Y41.3 Other antiprotozoal drugs
0.005 0.995 0.000
Y41.1 Antimycobacterial drugs
0.005 0.995 0.000
Y52.7 Peripheral vasodilators
0.005 0.995 0.000
O62 Abnormalities of forces of labour
0.000 0.995 0.005
Y48.2 Other and unspecified general anaesthetics
0.005 0.995 0.000
Y54.4 Loop [high-ceiling] diuretics
0.005 0.995 0.000
G20-G26 Extrapyramidal and movement disorders
0.005 0.995 0.000
G21.1 Other drug-induced secondary Parkinsonism
0.005 0.995 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
G21 Secondary Parkinsonism
0.005 0.995 0.000
Y52.1 Calcium-channel blockers
0.005 0.995 0.000
M81.4 Drug-induced osteoporosis
0.005 0.995 0.000
E06 Thyroiditis
0.000 0.995 0.005
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.995 0.000
Y59 Other and unspecified vaccines and biological substances
0.005 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.004 0.995 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.005 0.995 0.000
C81.0 Lymphocytic predominance
0.005 0.995 0.000
M81.9 Osteoporosis, unspecified
0.005 0.995 0.000
Y46.4 Iminostilbenes
0.004 0.995 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.995 0.000
Y46.5 Valproic acid
0.004 0.996 0.000
Y46.6 Other and unspecified antiepileptics
0.004 0.996 0.000
Y49.5 Other antipsychotics and neuroleptics
0.004 0.996 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
Y57 Other and unspecified drugs and medicaments
0.004 0.996 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.004 0.996 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.004 0.996 0.000
C81.7 Other Hodgkin's disease
0.004 0.996 0.000
Y58 Bacterial vaccines
0.004 0.996 0.000
M81 Osteoporosis without pathological fracture
0.004 0.996 0.000
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)
0.004 0.996 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.004 0.996 0.000
J86.0 Pyothorax with fistula
0.000 0.996 0.004
W11.6 Industrial and construction area
0.000 0.996 0.004
Y48.4 Anaesthetic, unspecified
0.004 0.996 0.000
Y49.2 Other and unspecified antidepressants
0.004 0.996 0.000
O62.0 Primary inadequate contractions
0.000 0.996 0.004
M25.59 Pain in joint (Site unspecified)
0.000 0.996 0.004
C81.2 Mixed cellularity
0.004 0.996 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.004 0.996 0.000
Y48.5 Therapeutic gases
0.004 0.996 0.000
Y48.1 Parenteral anaesthetics
0.004 0.996 0.000
Y48.0 Inhaled anaesthetics
0.004 0.996 0.000
G23 Other degenerative diseases of basal ganglia
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.004 0.996 0.000
Y48.3 Local anaesthetics
0.004 0.996 0.000
M81.91 Osteoporosis, unspecified (Shoulder region)
0.004 0.996 0.000
Y46.8 Antispasticity drugs
0.004 0.996 0.000
Y46.3 Deoxybarbiturates
0.004 0.996 0.000
Y46.1 Oxazolidinediones
0.004 0.996 0.000
Y46.0 Succinimides
0.004 0.996 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.004 0.996 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.004 0.996 0.000
C81.3 Lymphocytic depletion
0.004 0.996 0.000
Y49.9 Psychotropic drug, unspecified
0.004 0.996 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
Y49.7 Psychostimulants with abuse potential
0.004 0.996 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.004 0.996 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.004 0.996 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.004 0.996 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
Y57.5 X-ray contrast media
0.004 0.996 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.004 0.996 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.004 0.996 0.000
Y57.6 Other diagnostic agents
0.004 0.996 0.000
M81.90 Osteoporosis, unspecified (Multiple sites)
0.004 0.996 0.000
O62.8 Other abnormalities of forces of labour
0.000 0.996 0.004
Y42.9 Other and unspecified hormone antagonists
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
Y59.3 Immunoglobulin
0.004 0.996 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.004 0.996 0.000
G22 Parkinsonism in diseases classified elsewhere
0.004 0.996 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.004 0.996 0.000
Y53.7 Emetics
0.004 0.996 0.000
Y53.6 Antidiarrhoeal drugs
0.004 0.996 0.000
Y53.5 Digestants
0.004 0.996 0.000
Y53.3 Saline and osmotic laxatives
0.004 0.996 0.000
Y53.2 Stimulant laxatives
0.004 0.996 0.000
Y53.0 Histamine H2-receptor antagonists
0.004 0.996 0.000
M81.40 Drug-induced osteoporosis (Multiple sites)
0.004 0.996 0.000
M25.5 Pain in joint
0.000 0.996 0.004
G21.9 Secondary Parkinsonism, unspecified
0.004 0.996 0.000
G21.8 Other secondary Parkinsonism
0.004 0.996 0.000
G21.4 Vascular parkinsonism
0.004 0.996 0.000
G21.3 Postencephalitic Parkinsonism
0.004 0.996 0.000
G21.2 Secondary Parkinsonism due to other external agents
0.004 0.996 0.000
G21.0 Malignant neuroleptic syndrome
0.004 0.996 0.000
M81.3 Postsurgical malabsorption osteoporosis
0.004 0.996 0.000
Y59.0 Viral vaccines
0.004 0.996 0.000
M81.48 Drug-induced osteoporosis (Other)
0.003 0.996 0.000
M81.47 Drug-induced osteoporosis (Ankle and foot)
0.003 0.996 0.000
M81.46 Drug-induced osteoporosis (Lower leg)
0.003 0.996 0.000
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)
0.003 0.996 0.000
M81.44 Drug-induced osteoporosis (Hand)
0.003 0.996 0.000
M81.43 Drug-induced osteoporosis (Forearm)
0.003 0.996 0.000
M81.42 Drug-induced osteoporosis (Upper arm)
0.003 0.996 0.000
M81.41 Drug-induced osteoporosis (Shoulder region)
0.003 0.996 0.000
Y44 Agents primarily affecting blood constituents
0.004 0.996 0.000
M25.53 Pain in joint (Forearm)
0.000 0.996 0.004
E06.5 Other chronic thyroiditis
0.000 0.996 0.003
E06.4 Drug-induced thyroiditis
0.000 0.996 0.003
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.996 0.003
E06.1 Subacute thyroiditis
0.000 0.996 0.003
E06.0 Acute thyroiditis
0.000 0.996 0.003
Y46.7 Anti-Parkinsonism drugs
0.003 0.996 0.000
M81.97 Osteoporosis, unspecified (Ankle and foot)
0.004 0.996 0.000
Y59.9 Vaccine or biological substance, unspecified
0.003 0.996 0.000
Y59.8 Other specified vaccines and biological substances
0.003 0.996 0.000
Y59.2 Protozoal vaccines
0.003 0.996 0.000
Y59.1 Rickettsial vaccines
0.003 0.996 0.000
M81.92 Osteoporosis, unspecified (Upper arm)
0.003 0.996 0.000
R25.3 Fasciculation
0.000 0.996 0.004
Y47.1 Benzodiazepines
0.003 0.996 0.000
G25 Other extrapyramidal and movement disorders
0.004 0.996 0.000
M81.93 Osteoporosis, unspecified (Forearm)
0.003 0.996 0.000
O62.9 Abnormality of forces of labour, unspecified
0.000 0.996 0.003
M81.0 Postmenopausal osteoporosis
0.003 0.996 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.003 0.997 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.003 0.997 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.003 0.997 0.000
Y47.4 Bromine compounds
0.003 0.997 0.000
Y47.3 Paraldehyde
0.003 0.997 0.000
Y47.2 Chloral derivatives
0.003 0.997 0.000
Y47.0 Barbiturates, not elsewhere classified
0.003 0.997 0.000
R25 Abnormal involuntary movements
0.000 0.997 0.003
M25.54 Pain in joint (Hand)
0.000 0.997 0.003
R04.2 Haemoptysis
0.000 0.997 0.003
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
0.003 0.997 0.000
Y42.4 Oral contraceptives
0.003 0.997 0.000
Y50.9 Central nervous system stimulant, unspecified
0.003 0.997 0.000
Y50.8 Other central nervous system stimulants
0.003 0.997 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.003 0.997 0.000
Y50.1 Opioid receptor antagonists
0.003 0.997 0.000
Y50.0 Analeptics
0.003 0.997 0.000
Y57.7 Vitamins, not elsewhere classified
0.003 0.997 0.000
Y57.4 Pharmaceutical excipients
0.003 0.997 0.000
Y57.3 Alcohol deterrents
0.003 0.997 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.003 0.997 0.000
Y57.1 Lipotropic drugs
0.003 0.997 0.000
Y57.0 Appetite depressants [anorectics]
0.003 0.997 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.003 0.997 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.000 0.997 0.003
M25.58 Pain in joint (Other)
0.000 0.997 0.003
M81.30 Postsurgical malabsorption osteoporosis (Multiple sites)
0.003 0.997 0.000
Y58.9 Other and unspecified bacterial vaccines
0.003 0.997 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.003 0.997 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.003 0.997 0.000
Y58.5 Diphtheria vaccine
0.003 0.997 0.000
Y58.4 Tetanus vaccine
0.003 0.997 0.000
Y58.3 Plague vaccine
0.003 0.997 0.000
Y58.2 Cholera vaccine
0.003 0.997 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.003 0.997 0.000
G25.2 Other specified forms of tremor
0.003 0.997 0.000
M81.8 Other osteoporosis
0.003 0.997 0.000
M81.6 Localised osteoporosis [Lequesne]
0.003 0.997 0.000
M81.5 Idiopathic osteoporosis
0.003 0.997 0.000
M81.1 Postoophorectomy osteoporosis
0.003 0.997 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.003 0.997 0.000
Y53.4 Other laxatives
0.003 0.997 0.000
M81.94 Osteoporosis, unspecified (Hand)
0.003 0.997 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.003 0.997 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.003 0.997 0.000
Y55.5 Anticommon cold drugs
0.003 0.997 0.000
Y55.3 Antitussives
0.003 0.997 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.003 0.997 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.003 0.997 0.000
Y55.0 Oxytocic drugs
0.003 0.997 0.000
E06.9 Thyroiditis, unspecified
0.000 0.997 0.003
O62.1 Secondary uterine inertia
0.000 0.997 0.003
Y58.0 BCG vaccine
0.003 0.997 0.000
M81.00 Postmenopausal osteoporosis (Multiple sites)
0.003 0.997 0.000
G23.8 Other specified degenerative diseases of basal ganglia
0.003 0.997 0.000
M81.96 Osteoporosis, unspecified (Lower leg)
0.003 0.997 0.000
Y55.4 Expectorants
0.003 0.997 0.000
G23.9 Degenerative disease of basal ganglia, unspecified
0.003 0.997 0.000
G23.3 Multiple system atrophy, cerebellar type
0.003 0.997 0.000
G23.2 Striatonigral degeneration
0.003 0.997 0.000
G23.0 Hallervorden-Spatz disease
0.003 0.997 0.000
M54.29 Cervicalgia-Site unspe
0.003 0.997 0.000
U51.0 Not Previously admitted to a psyciatric hospital
0.000 0.997 0.003
Y46.2 Hydantoin derivatives
0.003 0.997 0.000
Y56.9 Topical agent, unspecified
0.003 0.997 0.000
Y56.8 Other topical agents
0.003 0.997 0.000
Y56.7 Dental drugs, topically applied
0.003 0.997 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.997 0.000
Y56.5 Ophthalmological drugs and preparations
0.003 0.997 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.997 0.000
Y56.3 Emollients, demulcents and protectants
0.003 0.997 0.000
Y56.2 Local astringents and local detergents
0.003 0.997 0.000
Y56.1 Antipruritics
0.003 0.997 0.000
H54.7 Unspecified visual loss
0.000 0.997 0.003
Y42.2 Antithyroid drugs
0.003 0.997 0.000
N94.3 Premenstrual tension syndrome
0.000 0.997 0.003
J02.9 Acute pharyngitis, unspecified
0.000 0.997 0.003
O62.4 Hypertonic, incoordinate and prolonged uterine contractions
0.000 0.997 0.003
G25.9 Extrapyramidal and movement disorder, unspecified
0.003 0.997 0.000
Y42.1 Thyroid hormones and substitutes
0.003 0.997 0.000
Y57.8 Other drugs and medicaments
0.003 0.997 0.000
T39.0 Salicylates
0.003 0.997 0.000
M81.39 Postsurgical malabsorption osteoporosis (Site unspecified)
0.003 0.997 0.000
M81.38 Postsurgical malabsorption osteoporosis (Other)
0.003 0.997 0.000
M81.37 Postsurgical malabsorption osteoporosis (Ankle and foot)
0.003 0.997 0.000
M81.36 Postsurgical malabsorption osteoporosis (Lower leg)
0.003 0.997 0.000
M81.35 Postsurgical malabsorption osteoporosis (Pelvic region and thigh)
0.003 0.997 0.000
M81.34 Postsurgical malabsorption osteoporosis (Hand)
0.003 0.997 0.000
M81.33 Postsurgical malabsorption osteoporosis (Forearm)
0.003 0.997 0.000
M81.32 Postsurgical malabsorption osteoporosis (Upper arm)
0.003 0.997 0.000
M81.31 Postsurgical malabsorption osteoporosis (Shoulder region)
0.003 0.997 0.000
Y44.5 Thrombolytic drugs
0.003 0.997 0.000
G25.0 Essential tremor
0.003 0.997 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.003 0.997 0.000
Y44.7 Plasma substitutes
0.003 0.997 0.000
Y44.6 Natural blood and blood products
0.003 0.997 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.003 0.997 0.000
G25.1 Drug-induced tremor
0.003 0.997 0.000
M25.34 Other instability of joint (Hand)
0.000 0.997 0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.003 0.997 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.003 0.997 0.000
G25.4 Drug-induced chorea
0.003 0.997 0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
M81.08 Postmenopausal osteoporosis (Other)
0.003 0.997 0.000
M81.07 Postmenopausal osteoporosis (Ankle and foot)
0.003 0.997 0.000
M81.06 Postmenopausal osteoporosis (Lower leg)
0.003 0.997 0.000
M81.05 Postmenopausal osteoporosis (Pelvic region and thigh)
0.003 0.997 0.000
M81.04 Postmenopausal osteoporosis (Hand)
0.003 0.997 0.000
M81.03 Postmenopausal osteoporosis (Forearm)
0.003 0.997 0.000
M81.02 Postmenopausal osteoporosis (Upper arm)
0.003 0.997 0.000
M81.01 Postmenopausal osteoporosis (Shoulder region)
0.003 0.997 0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters
0.000 0.997 0.003
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.997 0.003
J05.1 Acute epiglottitis
0.000 0.997 0.003
M81.2 Osteoporosis of disuse
0.003 0.997 0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]
0.003 0.997 0.000
G25.5 Other chorea
0.003 0.997 0.000
R25.0 Abnormal head movements
0.000 0.997 0.003
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.003 0.997 0.000
K04.8 Radicular cyst
0.003 0.997 0.000
Z11.5 Special screening examination for other viral diseases
0.003 0.997 0.000
W44.0 Home
0.000 0.997 0.003
M81.19 Postoophorectomy osteoporosis (Site unspecified)
0.002 0.997 0.000
M81.18 Postoophorectomy osteoporosis (Other)
0.002 0.997 0.000
M81.17 Postoophorectomy osteoporosis (Ankle and foot)
0.002 0.997 0.000
M81.16 Postoophorectomy osteoporosis (Lower leg)
0.002 0.997 0.000
M81.15 Postoophorectomy osteoporosis (Pelvic region and thigh)
0.002 0.997 0.000
M81.14 Postoophorectomy osteoporosis (Hand)
0.002 0.997 0.000
M81.13 Postoophorectomy osteoporosis (Forearm)
0.002 0.997 0.000
M81.12 Postoophorectomy osteoporosis (Upper arm)
0.002 0.997 0.000
M81.11 Postoophorectomy osteoporosis (Shoulder region)
0.002 0.997 0.000
M81.10 Postoophorectomy osteoporosis (Multiple sites)
0.002 0.997 0.000
M81.59 Idiopathic osteoporosis (Site unspecified)
0.002 0.997 0.000
M81.58 Idiopathic osteoporosis (Other)
0.002 0.997 0.000
M81.57 Idiopathic osteoporosis (Ankle and foot)
0.002 0.997 0.000
M81.56 Idiopathic osteoporosis (Lower leg)
0.002 0.997 0.000
M81.55 Idiopathic osteoporosis (Pelvic region and thigh)
0.002 0.997 0.000
M81.54 Idiopathic osteoporosis (Hand)
0.002 0.997 0.000
M81.53 Idiopathic osteoporosis (Forearm)
0.002 0.997 0.000
M81.52 Idiopathic osteoporosis (Upper arm)
0.002 0.997 0.000
M81.51 Idiopathic osteoporosis (Shoulder region)
0.002 0.997 0.000
M81.50 Idiopathic osteoporosis (Multiple sites)
0.002 0.997 0.000
M81.69 Localized osteoporosis [Lequesne] (Site unspecified)
0.002 0.997 0.000
M81.68 Localized osteoporosis [Lequesne] (Other)
0.002 0.997 0.000
M81.67 Localized osteoporosis [Lequesne] (Ankle and foot)
0.002 0.997 0.000
M81.66 Localized osteoporosis [Lequesne] (Lower leg)
0.002 0.997 0.000
M81.65 Localized osteoporosis [Lequesne] (Pelvic region and thigh)
0.002 0.997 0.000
M81.64 Localized osteoporosis [Lequesne] (Hand)
0.002 0.997 0.000
M81.63 Localized osteoporosis [Lequesne] (Forearm)
0.002 0.997 0.000
M81.62 Localized osteoporosis [Lequesne] (Upper arm)
0.002 0.997 0.000
M81.61 Localized osteoporosis [Lequesne] (Shoulder region)
0.002 0.997 0.000
M81.60 Localized osteoporosis [Lequesne] (Multiple sites)
0.002 0.997 0.000
M81.89 Other osteoporosis (Site unspecified)
0.002 0.997 0.000
M81.88 Other osteoporosis (Other)
0.002 0.997 0.000
M81.87 Other osteoporosis (Ankle and foot)
0.002 0.997 0.000
M81.86 Other osteoporosis (Lower leg)
0.002 0.997 0.000
M81.85 Other osteoporosis (Pelvic region and thigh)
0.002 0.997 0.000
M81.84 Other osteoporosis (Hand)
0.002 0.997 0.000
M81.83 Other osteoporosis (Forearm)
0.002 0.997 0.000
M81.82 Other osteoporosis (Upper arm)
0.002 0.997 0.000
M81.81 Other osteoporosis (Shoulder region)
0.002 0.997 0.000
M81.80 Other osteoporosis (Multiple sites)
0.002 0.997 0.000
U51.1 Previously admitted to a psychiatric hospital of the provider
0.000 0.997 0.003
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.997 0.000
M25.52 Pain in joint (Upper arm)
0.000 0.997 0.003
Z11 Special screening examination for infectious and parasitic diseases
0.003 0.997 0.000
Y42.5 Other oestrogens and progestogens
0.003 0.997 0.000
R25.1 Tremor, unspecified
0.000 0.997 0.003
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.997 0.000
U51 Admission status on psychiatric patients
0.000 0.997 0.003
Y51 Drugs primarily affecting the autonomic nervous system
0.002 0.997 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.002 0.997 0.000
Z11.8 Special screening examination for other infectious and parasitic diseases
0.003 0.997 0.000
J95.8 Other postprocedural respiratory disorders
0.000 0.997 0.003
Z11.1 Special screening examination for respiratory tuberculosis
0.002 0.997 0.000
Y42.7 Androgens and anabolic congeners
0.002 0.997 0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)
0.002 0.998 0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified
0.002 0.998 0.000
M62.88 Other specified disorders of muscle (Other)
0.002 0.998 0.000
Z11.2 Special screening examination for other bacterial diseases
0.002 0.998 0.000
M81.09 Postmenopausal osteoporosis (Site unspecified)
0.002 0.998 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.002 0.998 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.002 0.998 0.000
M62.8 Other specified disorders of muscle
0.002 0.998 0.000
C82.0 Small cleaved cell, follicular
0.002 0.998 0.000
Z83 Family history of other specific disorders
0.000 0.998 0.002
M81.29 Osteoporosis of disuse (Site unspecified)
0.002 0.998 0.000
M81.28 Osteoporosis of disuse (Other)
0.002 0.998 0.000
M81.27 Osteoporosis of disuse (Ankle and foot)
0.002 0.998 0.000
M81.26 Osteoporosis of disuse (Lower leg)
0.002 0.998 0.000
M81.25 Osteoporosis of disuse (Pelvic region and thigh)
0.002 0.998 0.000
M81.24 Osteoporosis of disuse (Hand)
0.002 0.998 0.000
M81.23 Osteoporosis of disuse (Forearm)
0.002 0.998 0.000
M81.22 Osteoporosis of disuse (Upper arm)
0.002 0.998 0.000
M81.21 Osteoporosis of disuse (Shoulder region)
0.002 0.998 0.000
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
0.002 0.998 0.000
D13.0 Oesophagus
0.000 0.998 0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.002 0.998 0.000
Y57.9 Drug or medicament, unspecified
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission
0.002 0.998 0.000
J36 Peritonsillar abscess
0.000 0.998 0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.998 0.000
M62.87 Other specified disorders of muscle (Ankle and foot)
0.002 0.998 0.000
Y45.4 Antirheumatics
0.002 0.998 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.002 0.998 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.002 0.998 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.002 0.998 0.000
Y51.0 Anticholinesterase agents
0.002 0.998 0.000
U51.2 Previously admitted to a psychiatric hospital of another provider
0.000 0.998 0.002
Z42.1 Follow-up care involving plastic surgery of breast
0.002 0.998 0.000
R25.8 Other and unspecified abnormal involuntary movements
0.000 0.998 0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.002 0.998 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.998 0.002
Y45.2 Propionic acid derivatives
0.002 0.998 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.002 0.998 0.000
C82.3 Follicular lymphoma grade IIIa
0.002 0.998 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.002 0.998 0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases
0.002 0.998 0.000
M25.3 Other instability of joint
0.000 0.998 0.002
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
M25.31 Other instability of joint (Shoulder region)
0.000 0.998 0.002
M80-M85 Disorders of bone density and structure
0.002 0.998 0.000
C82.4 Follicular lymphoma grade IIIb
0.002 0.998 0.000
C82.2 Large cell, follicular
0.002 0.998 0.000
Y45.1 Salicylates
0.002 0.998 0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods
0.002 0.998 0.000
M25.56 Pain in joint (Lower leg)
0.000 0.998 0.002
C85.1 B-cell lymphoma, unspecified
0.002 0.998 0.000
M62.84 Other specified disorders of muscle (Hand)
0.002 0.998 0.000
M62.80 Other specified disorders of muscle (Multiple sites)
0.002 0.998 0.000
M65.34 Trigger finger-Hand
0.002 0.998 0.000
C92.0 Acute myeloid leukaemia
0.000 0.998 0.002
G25.8 Other specified extrapyramidal and movement disorders
0.002 0.998 0.000
Z83.6 Family history of diseases of the respiratory system
0.000 0.998 0.002
G25.3 Myoclonus
0.002 0.998 0.000
M25.36 Other instability of joint (Lower leg)
0.000 0.998 0.002
K63.9 Disease of intestine, unspecified
0.000 0.998 0.002
Z83.0 Family history of human immunodeficiency virus [HIV]
0.000 0.998 0.002
L40.0 Psoriasis vulgaris
0.002 0.998 0.000
X51.9 Unspecified place
0.000 0.998 0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.001 0.998 0.000
W11 Fall on and from ladder
0.000 0.998 0.002
J02 Acute pharyngitis
0.000 0.998 0.002
M62.86 Other specified disorders of muscle (Lower leg)
0.002 0.998 0.000
M62.82 Other specified disorders of muscle (Upper arm)
0.002 0.998 0.000
C90.2 Plasmacytoma, extramedullary
0.002 0.998 0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum
0.002 0.998 0.000
F81 Specific developmental disorders of scholastic skills
0.000 0.998 0.002
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.002 0.998 0.000
M82 Osteoporosis in diseases classified elsewhere
0.002 0.998 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.002 0.998 0.000
C82.6 Cutaneous follicle centre lymphoma
0.002 0.998 0.000
C82.5 Diffuse follicle centre lymphoma
0.002 0.998 0.000
M84.03 Malunion of fracture (Forearm)
0.002 0.998 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.998 0.002
G24 Dystonia
0.001 0.998 0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.000 0.998 0.002
C85.0 Lymphosarcoma
0.002 0.998 0.000
M83 Adult osteomalacia
0.002 0.998 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.002 0.998 0.000
M62.81 Other specified disorders of muscle (Shoulder region)
0.002 0.998 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.000 0.998 0.002
M85 Other disorders of bone density and structure
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.